VivoSim Labs
VIVS
115 hedge funds and large institutions have $66.1M invested in VivoSim Labs in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 35 reducing their positions, and 8 closing their positions.
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
77% more capital invested
Capital invested by funds: $37.4M → $66.1M (+$28.7M)
6% more funds holding
Funds holding: 109 → 115 (+6)
0% less ownership
Funds ownership: 0.08% → 0.08% (-0%)
29% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 35
76% less call options, than puts
Call options by funds: $1.52M | Put options by funds: $6.23M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$786K |
| 2 |
D.E. Shaw & Co
New York
|
+$740K |
| 3 |
PM
Penbrook Management
New York
|
+$196K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$190K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$174K |
Top Sellers
VIVS Hedge Fund Activity: Q2 2016 in Review
115 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2016, worth a combined $66.1M — up 77% from $37.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new VIVS positions and 8 closed out — a net gain of 8 holders — while 25 added to existing stakes and 35 trimmed.
The largest buyer was Vanguard Group, adding an estimated $786K. The largest seller was LPL Financial, cutting an estimated $307K.
- 115 institutional investors held VivoSim Labs (VIVS) as of Q2 2016, up from 109 in Q1 2016.
- Funds reported $66.1M of VivoSim Labs stock for Q2 2016, up 77% quarter-over-quarter.
- 16 funds opened new VivoSim Labs positions in Q2 2016 and 8 closed out, a net change of +8 holders.
- The largest VivoSim Labs buyer in Q2 2016 was Vanguard Group, an estimated $786K added.
- The largest VivoSim Labs seller in Q2 2016 was LPL Financial, an estimated $307K sold.
Based on aggregated 13F filings for Q2 2016.